SEARCH

SEARCH BY CITATION

References

  • 1
    White, P.C., New, M.I. & Dupont, B. (1984) HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proceedings of the National Academy of Sciences of the United States of America, 81, 75057509.
  • 2
    White, P.C. & Speiser, P.W. (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews, 21, 245291.
  • 3
    Merke, D.P., Chrousos, G.P., Eisenhofer, G. et al. (2000) Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. New England Journal of Medicine, 343, 13621368.
  • 4
    Charmandari, E., Weise, M., Bornstein, S.R. et al. (2002) Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. Journal of Clinical Endocrinology and Metabolism, 87, 21142120.
  • 5
    Charmandari, E., Johnston, A., Brook, C.G. et al. (2001) Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Endocrinology, 169, 6570.
  • 6
    Charmandari, E., Hindmarsh, P.C., Johnston, A. et al. (2001) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. Journal of Clinical Endocrinology and Metabolism, 86, 27012708.
  • 7
    Falhammar, H. & Thorén, M. (2012) Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine, 41, 355373.
  • 8
    Speiser, P.W., Azziz, R., Baskin, L.S. et al. (2010) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 95, 41334160.
  • 9
    Roche, E.F., Charmandari, E., Dattani, M.T. et al. (2003) Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clinical Endocrinology (Oxf), 58, 589596.
  • 10
    Völkl, T.M., Simm, D., Beier, C. et al. (2006) Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics, 117, e98e105.
  • 11
    Falhammar, H., Filipsson, H., Holmdahl, G. et al. (2007) Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 92, 110116.
  • 12
    Arlt, W., Willis, D.S., Wild, S.H., (CaHASE), et al. (2010) Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. Journal of Clinical Endocrinology and Metabolism, 95, 51105121.
  • 13
    Falhammar, H., Filipsson Nyström, H., Wedell, A. et al. (2011) Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. European Journal of Endocrinology, 164, 285293.
  • 14
    Mooij, C.F., Kroese, J.M., Sweep, F.C. et al. (2011) Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profile. PLoS ONE, 6, e24204.
  • 15
    Finkielstain, G.P., Kim, M.S., Sinaii, N. et al. (2012) Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 97, 44294438.
  • 16
    Menard, J. & Catt, K.J. (1972) Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology, 90, 422430.
  • 17
    Freeman, J.V., Cole, T.J., Chinn, S. et al. (1995) Cross sectional stature and weight reference curves for the UK, 1990. Archives of Disease in Childhood, 73, 1724.
  • 18
    Wabitsch, M. (2000) Obesity in childhood and adolescence: recommendations of a United States of America Task Force for diagnosis and therapy. Klinische Padiatrie, 212, 287296.
  • 19
    National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and, Adolescents. (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics, 114(2 Suppl 4th Report), 555576.
  • 20
    Report of the Second Task Force on Blood Pressure Control in Children. (1987) Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics, 79, 125.
  • 21
    Hubert, H.B., Feinleib, M., McNamara, P.M. et al. (1983) Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation, 67, 968977.
  • 22
    Craig, R. & Mindell, J. eds. (2011) Health survey for England 2010. NHS Information Centre, London.
  • 23
    Muthusamy, K., Elamin, M.B., Smushkin, G. et al. (2010) Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. Journal of Clinical Endocrinology and Metabolism, 95, 41614172.
  • 24
    Völkl, T.M., Simm, D., Dötsch, J. et al. (2006) Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 91, 48884895.
  • 25
    Barker, M.E., Shiell, A.W. & Law, C.M. (2000) Evaluation of the Dinamap 8100 and Omron M1 blood pressure monitors for use in children. Paediatric and Perinatal Epidemiology, 14, 179186.
  • 26
    Völkl, T.M., Simm, D., Korner, A. et al. (2009) Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Acta Paediatrica, 98, 885891.
  • 27
    Sartorato, P., Zulian, E., Benedini, S. et al. (2007) Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 92, 10151018.
  • 28
    Bryan, S.M., Honour, J.W. & Hindmarsh, P.C. (2009) Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. Journal of Clinical Endocrinology and Metabolism, 94, 34773480.
  • 29
    Verma, S., Vanryzin, C., Sinaii, N. et al. (2010) A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clinical Endocrinology (Oxf), 72, 441447.